Cancer Center

Phone Numbers

Support Group Network
(803) 791-2800
Women's Imaging
(803) 791-2486
Lexington Radiation Oncology
(803) 791-2575
Lexington Oncology
(803) 794-7511

Prostate Cancer

Our Prostate Cancer Program

  • Less-invasive scanning procedures.
  • Monthly support group for patients and their loved ones.
  • 219 cases treated in 2014.

Treating Prostate Cancer

Because prostate cancer has a low mortality rate, many men who are diagnosed don't require treatment. Those who do need treatment most often undergo radiation. Your doctor will discuss options with you and decide what's best for your individual diagnosis.

Other Possible Treatments

 

  Terence N. Chapman, MD

Terence N. Chapman, MD Lexington Urology

Most experienced urologic robotic surgeon in the Midlands

Dr. Chapman has extensive training in the diagnosis and treatment of urologic cancer, including expertise in laparoscopic kidney surgery and robotic prostatectomy using the da Vinci Robot.

He serves as director of Urologic Oncology and is a board-certified physician at Lexington Urology providing comprehensive urologic care and advanced treatments for urologic conditions, including robotic and minimally invasive surgery. Learn More >>

Nurse Navigators

A nurse navigator will work with you through the whole treatment process. She'll help you understand your diagnosis, take care of scheduling, and coordinate with doctors to get you the answers and help you need.

Supportive Care

Our care is comprehensive, with support for your personal challenges that goes beyond the disease.

Just a few ways we help:

New Treatments

We’ve been on the cutting edge of treatment for 20 years, and work to bring in new techniques for our patients.

External Prostate Scans
Traditional scans require an imaging coil inside the body, but our new MR scan is all external, making the procedure much more comfortable for patients.

Research Trials

We offer qualifying patients access to the latest clinical trials.

Enroll in a Clinical Trial

(803) 935-8300

VERACITY-V3011102

Description
Randomized, Active-Controlled, Phase 3 Study of VERU111 for the Treatment of Metastatic Castration-Resistant Prostate Cancer in Patients who have Failed Prior Treatment with at Least One Androgen Receptor Targeting Agent.

Open to enrollment

Posted By: Dr. Steven Madden

Posted Date: 2/21/2022

Location:

BRAT

Description
The purpose of the Prostate BRAchyTherapy (BRAT) Registry is to measure clinical outcomes of patients treated with Brachytherapy at Lexington Medical Center (LMC).

Open to enrollment

Posted By: Dr. Quillin Davis

Posted Date: 11/1/2021

Location: Lexington Oncology

EA8184

Description
To Evaluate if Green Tea can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring.

This study is being done to answer the following question:  Can we lower the chance of your prostate cancer growing by adding Sunphenon® 90D (containing green tea catechins) by closely monitoring your prostate cancer?

Open to enrollment

Posted By: Dr. T. Brian Willard

Posted Date: 11/1/2021

Location: Lexington Urology